期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

FBC方案预处理进行异基因造血干细胞移植的临床研究 被引量：2

下载PDF
导出
摘要 造血干细胞移植对根治恶性血液病的作用已得到充分肯定,但传统预处理方案所用的致死性放、化疗剂量对患者心、肝、肾等重要脏器有进一步损伤,致使移植相关死亡率一直居高不下 [1].为降低预处理的毒性,我们对14例恶性血液病患者进行了FBC预处理方案的异基因造血干细胞移植.
作者 黄宁 葛林阜 马焕文 刘希民 郭鹏
机构地区 济南军区总医院血液科
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2005年第2期150-151,共2页 Chinese Journal of Cancer Biotherapy
关键词 造血干细胞移植 异基因 恶性血液病 预处理方案
分类号 R733.7 [医药卫生—肿瘤] R457.7 [医药卫生—治疗学]
  • 相关文献

参考文献3

二级参考文献11

  • 1张之南，血液病诊断及疗效标准（第2版），1998年，36页
  • 2Cchleuning M.Adoptive allogeneic immunotherapy-history and future perspectives[].Transfusion Science.2000
  • 3van Rhee F,Savage D,Blackwell J,et al.Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant : equal efficacy of lymphocyte from sibling and matched unrelated donors[].Bone Marrow Transplantation.1998
  • 4Mackinnon S,Papadopoulos EB,Carabasi MH,et al.Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease[].Blood.1995
  • 5Georges GE,Storb R,Thompson JD,et al.Adoptive immunotherapy in canine mixed chimerase after nonmyeloablative hematopoietic cell transplantation[].Blood.2000
  • 6Colby C,Sykes M,Sachs DH,et al.Cellular modulation of acute graftvs-host disease[].Biology of Blood and Marrow Transplantation.1997
  • 7Bordignon C,Carlo-Stella C,Colombo MP,et al.Cell therapy: achievement and perspectives[].Haematologica.1999
  • 8Bishop MR,Tarantolo SR,Pavletic ZS,et al.Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantation[].Journal of Clinical Oncology.2000
  • 9Dazzi F,Szydlo RM,Craddock C,et al.Comparison of single-dose and escalating-dose regimems of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia[].Blood.2000
  • 10Wu CJ,Yang XF,Mclaughlin S,et al.detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia[].The Journal of Clinical Investigation.2000

共引文献22

同被引文献24

  • 1Zelenetz AD,Abramson JS,Advani RH,et al.Non-Hodgkin′sLymphomas[J].J Natl Compr Canc Netw,2011,9(5):484-560.
  • 2Peniket AJ,Ruiz de Elvira MC,Taghipour G,et al.An EBMTregistry matched study of allogeneic stem cell transplants forlymphoma:allogeneic transplantation is associated with a lowerrelapse rate but a higher procedure-related mortality rate thanautologous transplantation[J].Bone Marrow Transplantation,2003,31(8),667-678.
  • 3Slavin S,Nagler A,Naparstek E,et al.Nonmyeloablative stemcell transplantation and cell therapy as an alternative toconventional bone marrow transplantation with lethalcytoreduction for the treatment of malignant and nonmalignanthematologic diseases[J].Blood,1998,91(3):756-763.
  • 4Bloor AJ,Thomson K,Chowdhry N,et al.High response rateto donor lymphocyte infusion after allogeneic stem celltransplantation for indolent non-Hodgkin lymphoma[J].BiolBlood Marrow Transplant,2008,14(1):50-58.
  • 5Calvo-Villas JM,Martin A,Conde E,et al.Effect of addition ofrituximab to salvage chemotherapy on outcome of patients withdiffuse large B-cell lymphoma relapsing after an autologousstem-cell transplantation[J].Ann Oncol,2010,21(9):1891-1897.
  • 6Gisselbrecht C,Glass B,Mounier N,et al.Salvage regimenswith autologous transplantation for relapsed large B-celllymphoma in the rituximab era[J].Ann Oncol,2010,28(27):4184-4190.
  • 7Thomson KJ, Peggs KS, Smith P, et al. Superiority of reduced- intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation. Bone Marrow Transplant, 2008, 41 : 765-770.
  • 8Sorror ML, Storer BE, Maloney DG, et al. Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia. Blood, 2008, 111 : 446-452.
  • 9le Blanc K, Remberger M, Uzunel M, et al. A comparison of nnnmyeloablai''e and reduced-intensity conditioning for allogeneic stem-cell transplantation. Transplantation, 2004, 78:1014-1020.
  • 10Kuruvilla J, Keating A, Crump M. How I treat relapsed and refractory Hedgkin lymphoma. Blox/d, 2011, 117:4208-4217.

引证文献2

二级引证文献1

中国肿瘤生物治疗杂志
2005年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部